Coronary artery disease and human immunodeficiency virus infection (Q34052597)

30 July 2017

1 reference

title

Coronary artery disease and human immunodeficiency virus infection (English)

1 reference

30 July 2017

main subject

coronary artery disease

1 reference

Passalaris JD

1

1 reference

30 July 2017

Sepkowitz KA

series ordinal

2

1 reference

30 July 2017

Glesby MJ

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Clinical Infectious Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

31

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

787-797

1 reference

Cardiac involvement in acquired immunodeficiency syndrome--a review to push action. The Committee for the Study of Cardiac Involvement in AIDS.

30 July 2017

cites work

1 reference

Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management

21 January 2018

1 reference

Coronary artery lesions and human immunodeficiency virus infection

21 January 2018

1 reference

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

21 January 2018

1 reference

A reliable marker of endothelial cell dysfunction: does it exist?

21 January 2018

1 reference

Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

21 January 2018

1 reference

Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.

21 January 2018

1 reference

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

21 January 2018

1 reference

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors

21 January 2018

1 reference

Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

21 January 2018

1 reference

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

Protease inhibitors and adipocyte differentiation in cell culture.

21 January 2018

1 reference

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

21 January 2018

1 reference

Lipodystrophy in patients naive to HIV protease inhibitors

21 January 2018

1 reference

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

Editorial Response: What Price Progress? Pseudo‐Cushing's Syndrome Associated with Antiretroviral Therapy in Patients with Human Immunodeficiency Virus Infection

21 January 2018

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

Myocardial infarction in HIV-infected men receiving protease inhibitors

21 January 2018

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

Drug treatment of lipid disorders

21 January 2018

1 reference

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine

21 January 2018

1 reference

Differences in phenotypic expression of a new BRCA1 mutation in identical twins

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313995

1 reference

30 July 2017

1 reference